These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9767617)

  • 1. Clinical efficacy of the FLUTTER device for airway mucus clearance in patients with diffuse panbronchiolitis.
    Burioka N; Sugimoto Y; Suyama H; Hori S; Chikumi H; Sasaki T
    Respirology; 1998 Sep; 3(3):183-6. PubMed ID: 9767617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute effect of use of the Flutter on expectoration of sputum in patients with chronic respiratory diseases].
    Nakamura S; Kawakami M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Feb; 34(2):180-5. PubMed ID: 8622274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis.
    Konstan MW; Stern RC; Doershuk CF
    J Pediatr; 1994 May; 124(5 Pt 1):689-93. PubMed ID: 8176554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an Airway Clearance Device on Inflammation, Bacteriology, and Mucus Transport in Bronchiectasis.
    Tambascio J; de Souza HCD; Martinez R; Baddini-Martinez JA; Barnes PJ; Gastaldi AC
    Respir Care; 2017 Aug; 62(8):1067-1074. PubMed ID: 28733314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of treadmill exercise versus Flutter® on respiratory flow and sputum properties in adults with cystic fibrosis: a randomised, controlled, cross-over trial.
    Dwyer TJ; Zainuldin R; Daviskas E; Bye PT; Alison JA
    BMC Pulm Med; 2017 Jan; 17(1):14. PubMed ID: 28077104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of 2 Respiratory Devices for Sputum Clearance in Adults With Non-Cystic Fibrosis Bronchiectasis.
    Silva YR; Greer TA; Morgan LC; Li F; Farah CS
    Respir Care; 2017 Oct; 62(10):1291-1297. PubMed ID: 28634173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage.
    App EM; Kieselmann R; Reinhardt D; Lindemann H; Dasgupta B; King M; Brand P
    Chest; 1998 Jul; 114(1):171-7. PubMed ID: 9674466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of the FLUTTER VRP1 device for physiotherapy patients with chronic pulmonary disease].
    Lubiński W; Targowski T; Frank-Piskorska A
    Pol Merkur Lekarski; 2000 Jan; 7(43):37-40. PubMed ID: 10765651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis.
    van Winden CM; Visser A; Hop W; Sterk PJ; Beckers S; de Jongste JC
    Eur Respir J; 1998 Jul; 12(1):143-7. PubMed ID: 9701429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the efficiency of selected thoracic physiotherapy methods used in the treatment of patients with cystic fibrosis].
    Orlik T
    Med Wieku Rozwoj; 2000; 4(3):233-46. PubMed ID: 11093341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Flutter device and chest physical therapy in the treatment of cystic fibrosis pulmonary exacerbation.
    Gondor M; Nixon PA; Mutich R; Rebovich P; Orenstein DM
    Pediatr Pulmonol; 1999 Oct; 28(4):255-60. PubMed ID: 10497374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of 32 cases of diffuse panbronchiolitis.
    Zhang L; Ou Y; Hu H; Shen C; Cao Y; Chen Z; Ouyang R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):330-338. PubMed ID: 37164916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiotherapy in chronic obstructive pulmonary disease: oscillatory breathing with flutter VRP1].
    Weiner P; Zamir D; Waizman J; Weiner M
    Harefuah; 1996 Jul; 131(1-2):14-7, 71. PubMed ID: 8854470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sputum oscillations and rhDNase in vitro: a combined approach to treat cystic fibrosis lung disease.
    Dasgupta B; Brown NE; King M
    Pediatr Pulmonol; 1998 Oct; 26(4):250-5. PubMed ID: 9811074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial.
    Herrero-Cortina B; Vilaró J; Martí D; Torres A; San Miguel-Pagola M; Alcaraz V; Polverino E
    Physiotherapy; 2016 Dec; 102(4):357-364. PubMed ID: 26712530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the Flutter Valve improve respiratory mechanics and sputum production in mechanically ventilated patients? A randomized crossover trial.
    Chicayban LM; Zin WA; Guimarães FS
    Heart Lung; 2011; 40(6):545-53. PubMed ID: 21784525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis.
    Kadota J; Mukae H; Ishii H; Nagata T; Kaida H; Tomono K; Kohno S
    Respir Med; 2003 Jul; 97(7):844-50. PubMed ID: 12854636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis.
    Thompson CS; Harrison S; Ashley J; Day K; Smith DL
    Thorax; 2002 May; 57(5):446-8. PubMed ID: 11978924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory IgA(S-IgA) levels in sera from patients with diffuse panbronchiolitis.
    Noda Y; Yasuoka S; Tani K; Ogura T; Ogawara M; Kitatani F
    Jpn J Med; 1989; 28(2):189-95. PubMed ID: 2733243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of PEP mask and Flutter on expectoration in cystic fibrosis patients.
    Borka P; Gyurkovits K; Bódis J
    Acta Physiol Hung; 2012 Sep; 99(3):324-31. PubMed ID: 22982720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.